Larvol Delta - Treatment-of-mCRPC-with-LYNPARZA-An-oral-therapy-for-patients-with-HRR-gene-mutations-following-progression-on-enzalutamide-or-abiraterone

Xtandi (enzalutamide) - Pfizer, Astellas, Bausch Health

Yonsa (abiraterone acetate) - Churchill Pharma, Sun Pharma

Lynparza (olaparib) - Merck (MSD), AstraZeneca

https://rmusweb.org/docs/meetings/rmus2104/exhibit-guide.aspx

Lawrence Karsh, MD, FACS, CPI

Apr 16, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next